Peptide Portfolio
CJC-1295/Ipamorelin
BPC-157/TB-500
GHK-Cu
GROWTH & REPAIR, IMMUNE & INFLAMMATORY, HAIR & AESTHETICS
CJC-1295/IPAMORELIN
CJC-1295/Ipamorelin is a blend of two complementary peptides designed to enhance growth hormone secretion in research settings. CJC-1295 stimulates the pituitary gland by mimicking GHRH, while Ipamorelin targets ghrelin receptors to amplify the release of growth hormone. Supplied in lyophilized powder form for research purposes, this combination is widely studied for its potential effects on cellular repair, metabolism, and tissue regeneration.
$249.00 / month
FREE Shipping on orders over $200
MOLECULAR FORMULA:
C152H252N44042 / C38H49N905
Quantity Discounts Available
Product Usage: For Research Use Only
Peptide products offered through this platform are provided for informational and research purposes or are made available only pursuant to evaluation and authorization by a licensed healthcare provider, where applicable. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Use of any peptide product should be conducted under appropriate professional supervision. All content provided is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before beginning any new wellness or medical program.
The GHRH/GHRP Synergistic Axis
The CJC-1295 (No DAC) + Ipamorelin Blend is a lyophilized synergistic complex designed for researchers studying the maximum potential of endogenous growth hormone release. By combining a GHRH (Growth Hormone Releasing Hormone) analog with a GHRP (Growth Hormone Releasing Peptide), scientists can evaluate the ‘amplifier effect’ that occurs when both receptor types are activated simultaneously. This reagent is specifically valued for its precision; Ipamorelin provides highly selective GH release, while the No DAC modification of the CJC-1295 ensures the natural pulsatile rhythm is preserved rather than suppressed. This allows for the study of metabolic shifts, tissue architectural restoration, and lipid oxidation in a controlled, laboratory environment. Supplied as a purified powder, it is intended strictly for laboratory research; it is not for human or veterinary administration.
Chemical Info
| CAS Number | 863288-34-0 | 170851-70-4 |
| PubChem CID | 91976842 | 9831659 |
| Molecular Weight | 3367.9 g/mol | 711.9 g/mol |
| Molecular Formula | C152H252N44O42 | C38H49N9O5 |
| Synonyms | Modified GRF (1-29), Mod GRF 1-29, NNC-26-0161 | |
| Purity | ≥ 99% HPLC | |
Storage
Store in lyophilized form at -20°C to maintain compound stability.
Store protected from direct light exposure to reduce degradation.
Keep totally dry and avoid moisture exposure prior to reconstitution.
Keep vial tightly sealed when not in use to preserve integrity.
The GHRH/GHRP Synergistic Axis
The primary focus of this blend is the investigation of ‘Dual-Receptor Synergism.’ In pituitary research, it has been observed that GHRH and GHRP work through different intracellular pathways (cAMP and PLC/IP3, respectively). When administered together, they have been shown to produce a GH release that is significantly greater than the sum of the two parts. Researchers use this blend to determine the optimal ratios required to maximize this ‘Double Pulse’ while avoiding receptor desensitization.
Metabolic Signaling & Body Composition
In metabolic studies, this complex is utilized to observe the secondary effects of elevated GH on the IGF-1 axis. By stimulating the liver to produce IGF-1 in a pulsatile manner, researchers can monitor changes in nitrogen retention, protein synthesis, and collagen deposition. This research is vital for understanding how specific secretagogue stacks can influence the structural restoration of skeletal muscle and connective tissue in animal models of atrophy or injury.